{"id":"https://openalex.org/W648038587","doi":null,"title":"Exploration of cognitive and neurochemical deficits in an animal model of schizophrenia. Investigation into sub-chronic PCP-induced cognitive deficits using behavioural, neurochemical and electrophysiological techniques; and use of receptor-selective agents to study the pharmacology of antipsychotics in female rats.","display_name":"Exploration of cognitive and neurochemical deficits in an animal model of schizophrenia. Investigation into sub-chronic PCP-induced cognitive deficits using behavioural, neurochemical and electrophysiological techniques; and use of receptor-selective agents to study the pharmacology of antipsychotics in female rats.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-19","ids":{"openalex":"https://openalex.org/W648038587","mag":"648038587"},"language":"en","primary_location":{"id":"pmh:oai:bradscholars.brad.ac.uk:10454/4451","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10454/4451","pdf_url":null,"source":{"id":"https://openalex.org/S4306401846","display_name":"Bradford Scholars (University of Bradford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139894009","host_organization_name":"University of Bradford","host_organization_lineage":["https://openalex.org/I139894009"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"parent_works":[],"lineage":["https://openalex.org/W648038587"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/10454/4451","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020568062","display_name":"amantha Louise","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"amantha Louise","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5083287217","display_name":"Samantha Louise","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Samantha Louise","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.8989999890327454},{"id":"https://openalex.org/keywords/set-shifting","display_name":"set-shifting","score":0.9179999828338623},{"id":"https://openalex.org/keywords/reversal-learning","display_name":"reversal learning","score":0.8769999742507935},{"id":"https://openalex.org/keywords/novel-object-recognition","display_name":"novel object recognition","score":0.9470000267028809},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.8640000224113464},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8820000290870667},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9549999833106995},{"id":"https://openalex.org/keywords/isolation-rearing","display_name":"isolation rearing","score":0.7519999742507935},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.796999990940094},{"id":"https://openalex.org/keywords/d1-receptor-agonists","display_name":"D1 receptor agonists","score":0.6899999976158142},{"id":"https://openalex.org/keywords/antipsychotic-pharmacology","display_name":"antipsychotic pharmacology","score":0.7580000162124634},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.6809999942779541},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.6779999732971191},{"id":"https://openalex.org/keywords/extracellular-dopamine","display_name":"extracellular dopamine","score":0.5210000276565552},{"id":"https://openalex.org/keywords/extracellular-serotonin","display_name":"extracellular serotonin","score":0.3779999911785126},{"id":"https://openalex.org/keywords/extracellular-gaba","display_name":"extracellular GABA","score":0.6480000019073486},{"id":"https://openalex.org/keywords/extracellular-glutamate","display_name":"extracellular glutamate","score":0.6779999732971191},{"id":"https://openalex.org/keywords/extracellular-acetylcholine","display_name":"extracellular acetylcholine","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.969741940498352},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7064847946166992},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6990131139755249},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.635821521282196},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4949478507041931},{"id":"https://openalex.org/C185263204","wikidata":"https://www.wikidata.org/wiki/Q1154774","display_name":"Electrophysiology","level":2,"score":0.4583110511302948},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.4513043165206909},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.43872368335723877},{"id":"https://openalex.org/C2780749935","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive deficit","level":4,"score":0.4277956485748291},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3737465739250183},{"id":"https://openalex.org/C2984915365","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive impairment","level":3,"score":0.27489739656448364},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27169910073280334},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.25779443979263306},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22556418180465698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08459043502807617}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:bradscholars.brad.ac.uk:10454/4451","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10454/4451","pdf_url":null,"source":{"id":"https://openalex.org/S4306401846","display_name":"Bradford Scholars (University of Bradford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139894009","host_organization_name":"University of Bradford","host_organization_lineage":["https://openalex.org/I139894009"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"mag:648038587","doi":null,"is_oa":false,"landing_page_url":"https://bradscholars.brad.ac.uk/bitstream/10454/4451/4/THESIS%20changed%20final.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:bradscholars.brad.ac.uk:10454/4451","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10454/4451","pdf_url":null,"source":{"id":"https://openalex.org/S4306401846","display_name":"Bradford Scholars (University of Bradford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139894009","host_organization_name":"University of Bradford","host_organization_lineage":["https://openalex.org/I139894009"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W634470400","https://openalex.org/W7128145626","https://openalex.org/W2220320715","https://openalex.org/W187827840","https://openalex.org/W2126316244","https://openalex.org/W276958651","https://openalex.org/W2565946","https://openalex.org/W874317147","https://openalex.org/W7111941592","https://openalex.org/W2052781981"],"abstract_inverted_index":{"Cognitive":[0],"dysfunction":[1,67,674],"is":[2,31,142,166,257,586],"a":[3,32,143,161,192,298,302,307,419,422,473,497,506,516,622],"core":[4],"characteristic":[5,43],"of":[6,44,52,99,145,201,210,260,289,318,457,461,482,592],"schizophrenia,":[7],"which":[8,71,194,529,585],"can":[9],"often":[10],"persist":[11],"when":[12,373,386],"other":[13],"symptoms,":[14,17],"particularly":[15],"positive":[16,315],"may":[18,662],"be":[19,216,416,663],"improved":[20],"with":[21,170,446],"drug":[22,35],"treatment.":[23],"The":[24,82,97,172,208],"non-competitive":[25],"NMDA":[26],"receptor":[27,109,323],"antagonist,":[28],"phencyclidine":[29],"(PCP),":[30],"psychomotor":[33],"stimulant":[34],"that":[36,179,266,297,410,493,564,574,629,650],"has":[37],"been":[38,73],"shown":[39,214,628],"to":[40,56,64,129,154,157,160,215,223,330,359,376,388,402,430,562,602,665,685],"induce":[41,634],"symptoms":[42,636],"schizophrenia":[45],"in":[46,62,68,103,119,123,126,168,175,188,219,227,233,274,285,336,469,475,478,499,519,545,580,582,613,616,637,656,669,675,688],"humans":[47],"and":[48,92,122,203,311,314,325,347,371,437,607,610,642,659,672,680],"animals.":[49],"\\nThe":[50,138,253,466],"aim":[51],"these":[53,354,660],"studies":[54,173,467,648],"was":[55,101,195,212,230,295,399,494,522,535,569,619,626],"use":[57],"the":[58,78,104,131,134,148,155,189,238,247,286,290,319,332,361,367,394,411,428,433,442,447,455,458,479,483,546,551,565,583,589,593,605,611,638,670,676],"sub-chronic":[59,180,199,267,333,486,566,630,651],"PCP":[60,181,211,242,268,398,487,552,567,631,652],"model":[61],"rats":[63,221,378,390,426,439,576,599,618],"investigate":[65,130],"cognitive":[66,136,654],"behavioural":[69,657,679],"tests":[70,84,557],"have":[72,342],"highlighted":[74],"as":[75,278,418],"relevance":[76],"by":[77,198,241,250,280,496],"MATRICS":[79],"initiative":[80],"(MATRICS.ucla.edu).":[81],"main":[83],"used":[85],"were":[86,115,243,356,543,558,600],"attentional":[87,139,184],"set-shifting,":[88],"operant":[89,276],"reversal":[90,105,254,271,287,291,337,383,404,451],"learning,":[91],"novel":[93,594,606],"object":[94,595],"recognition":[95,596],"tasks.":[96],"pharmacology":[98],"antipsychotics":[100,341,462],"studied":[102],"learning":[106,255,272,292,405],"task":[107,141,256],"using":[108,118],"selective":[110,351,464,587],"compounds.":[111,465],"Following":[112,421],"this,":[113],"experiments":[114,408],"carried":[116,560],"out":[117,561],"vitro":[120],"electrophysiology":[121],"vivo":[124],"microdialysis":[125,572],"an":[127,275,312,578],"attempt":[128],"mechanisms":[132],"underpinning":[133],"PCP-induced":[135,334,362],"deficits.":[137],"set-shifting":[140,185,228],"test":[144,259],"executive":[146,261],"function,":[147],"extra-dimensional":[149],"shift":[150,158],"(EDS)":[151],"phase":[152,288,452],"relates":[153],"ability":[156,229,273,429],"attention":[159],"different":[162],"stimulus":[163],"dimension;":[164],"this":[165],"impaired":[167,183,391],"patients":[169],"schizophrenia.":[171,689],"presented":[174,468],"chapter":[176,365,470],"2":[177,412],"showed":[178],"administration":[182,200,269],"performance":[186,392],"selectively":[187],"EDS":[190],"phase,":[191],"deficit":[193,226,248,335,498],"significantly":[196],"attenuated":[197],"clozapine":[202,370,436],"risperidone,":[204,372],"but":[205],"not":[206,357,633],"haloperidol.":[207],"effect":[209,381],"also":[213,231,559,627],"more":[217,244],"robust":[218,245],"female":[220],"compared":[222],"males.":[224],"A":[225],"observed":[232,523,615,687],"isolation":[234,251],"reared":[235],"rats.":[236],"However,":[237],"deficits":[239,655,661],"produced":[240,249],"than":[246],"rearing.":[252],"another":[258],"function.":[262],"Chapter":[263],"3":[264],"reported":[265],"impairs":[270],"task,":[277],"demonstrated":[279],"reduced":[281],"percent":[282],"correct":[283],"responding":[284],"task.":[293,597],"It":[294],"found":[296,401,472],"D1":[299],"agonist":[300,305,313],"(SKF-38398),":[301],"5-HT1A":[303],"partial":[304],"(buspirone),":[306],"5-HT2C":[308],"antagonist":[309],"(SB-243213A)":[310],"allosteric":[316],"modulator":[317],"alpha":[320],"7":[321],"nACh":[322],"(PNU-282987":[324],"PheTQS":[326],"respectively)":[327],"are":[328,683],"able":[329,358],"reverse":[331],"learning.":[338,384],"Although":[339],"many":[340],"affinity":[343],"for":[344,588],"muscarinic":[345],"M1":[346],"histamine":[348],"H1":[349],"receptors,":[350],"agents":[352],"at":[353,393,505,528],"receptors":[355],"improve":[360],"deficit.":[363],"\\nIn":[364],"4,":[366],"atypical":[368],"antipsychotics,":[369],"given":[374,387],"alone":[375],"na\u00efve":[377,389],"had":[379],"no":[380],"on":[382],"Haloperidol":[385],"highest":[395],"dose.":[396],"Sub-chronic":[397],"again":[400],"impair":[403],"performance.":[406],"Investigative":[407],"revealed":[409,573],"min":[413],"time-out":[414],"could":[415,440,453],"important":[417],"cue.":[420],"double":[423,443],"reversal,":[424],"olanzapine-treated":[425],"lost":[427],"switch":[431],"between":[432,604],"rules,":[434],"whereas":[435],"risperidone-treated":[438],"perform":[441],"reversal.":[444],"Experiments":[445],"extended":[448],"(15":[449],"min)":[450],"allow":[454],"investigation":[456],"time-course":[459],"effects":[460],"or":[463],"5":[471],"reduction":[474],"gamma":[476,520],"oscillations":[477,521,542],"CA3":[480],"region":[481],"hippocampus,":[484],"following":[485,550],"treatment":[488,553,568],"(2-5":[489],"weeks":[490,511,525,538],"post":[491,512,526,539],"treatment)":[492],"paralleled":[495],"parvalbumin":[500,531],"immunoreactive":[501],"(IR)":[502],"cell":[503,533],"density,":[504],"similar":[507],"time":[508],"point":[509,530],"(2":[510],"treatment).":[513,540],"In":[514],"contrast,":[515],"time-dependent":[517],"increase":[518,579,612],"(6-8":[524],"treatment),":[527],"IR":[532],"density":[534],"unchanged":[536,544],"(8":[537],"Gamma":[541],"prefrontal":[547],"cortex":[548],"(PFC)":[549],"regime.":[554],"Locomotor":[555],"activity":[556],"ensure":[563],"successful.":[570],"\\nIn-vivo":[571],"vehicle-treated":[575],"show":[577],"dopamine":[581,614],"PFC":[584],"retention":[590],"trial":[591],"PCP-treated":[598],"unable":[601],"distinguish":[603],"familiar":[608],"objects":[609],"vehicle":[617],"absent.":[620],"As":[621],"control":[623],"experiment":[624],"it":[625],"did":[632],"anxiety-like":[635],"elevated":[639],"plus":[640],"maze":[641],"open":[643],"field":[644],"tests.":[645],"\\t":[646],"\\nThese":[647],"suggest":[649],"induces":[653],"tasks,":[658],"due":[664],"GABAergic":[666],"mediated":[667],"processes":[668],"hippocampus":[671],"dopaminergic":[673],"PFC.":[677],"These":[678],"neurochemical":[681],"results":[682],"concurrent":[684],"findings":[686]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W648038587","counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}
